KDR and esophageal squamous cell carcinoma: The results showed enhanced invasion of human ESCC cells within 24 h, and that blocking VEGFR1 on bone marrow cells with MF-1, or VEGFR2 with DC101, partially abolished this effect (Figure 5D).